The pharmaceutical company said it made an application to AIM for the admission of 1.6 million VCT shares occuring early on Wednesday. It also requested to place 3.9 million shares and 3.2 million convertible loan shares on Thursday.
Diurnal said it will have 54.2 million shares after VCT shares admission and 61.3 million shares following both admissions.
The stock was trading 1.5% lower at